Joseph H Chewning
Overview
Explore the profile of Joseph H Chewning including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lai B, Chaviano K, Richman J, Ahmad M, Wright A, Young R, et al.
JMIR Res Protoc
. 2024 Dec;
13():e64879.
PMID: 39714090
Background: Pediatric patients with cancer have limited options to self-manage their health while they are undergoing treatments in the hospital and after they are discharged to their homes. Extended reality...
2.
Hightower H, Young J, Thomas J, Smith J, Hobby-Noland D, Palombo G, et al.
Pediatr Qual Saf
. 2024 Apr;
7(6):e610.
PMID: 38585503
Introduction: Critically ill neonates and those with complex medical conditions frequently require the use of central venous lines. Unfortunately, central line-associated bloodstream infections (CLABSIs) result in significant morbidity and mortality,...
3.
Cuvelier G, Ng B, Abdossamadi S, Nemecek E, Melton A, Kitko C, et al.
Blood Adv
. 2022 Oct;
7(14):3612-3623.
PMID: 36219586
The National Institutes of Health Consensus criteria for chronic graft-versus-host disease (cGVHD) diagnosis can be challenging to apply in children, making pediatric cGVHD diagnosis difficult. We aimed to identify diagnostic...
4.
Tarlock K, Sulis M, Chewning J, Pollard J, Cooper T, Gamis A, et al.
Transplant Cell Ther
. 2022 Jun;
28(9):530-545.
PMID: 35717004
The role of allogeneic hematopoietic stem cell transplantation (HCT) in the treatment of acute myelogenous leukemia (AML) in children is reviewed and critically evaluated in this evidence-based review. Specific criteria...
5.
Subburaj D, Ng B, Kariminia A, Abdossamadi S, Lauener M, Nemecek E, et al.
Blood
. 2021 Sep;
139(2):287-299.
PMID: 34534280
Chronic graft-versus-host disease (cGVHD) is the most common cause for non-relapse mortality postallogeneic hematopoietic stem cell transplant (HSCT). However, there are no well-defined biomarkers for cGVHD or late acute GVHD...
6.
Falcon C, Broglie L, Phelan R, Choi S, Auletta J, Chewning J
Pediatr Transplant
. 2020 Aug;
24(8):e13821.
PMID: 32844543
No standardized guidelines exist for infectious prophylaxis following pediatric auto-HSCT. We hypothesized significant variation in clinical practice. Thirty-three Pediatric Transplant and Cell Therapy Consortium centers completed a survey to assess...
7.
Schultz K, Kariminia A, Ng B, Abdossamadi S, Lauener M, Nemecek E, et al.
Blood
. 2020 Feb;
135(15):1287-1298.
PMID: 32047896
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transplantation (HSCT) is complex. The Applied Biomarker in Late Effects of Childhood Cancer study (ABLE/PBMTC1202, NCT02067832) evaluated the...
8.
Cuvelier G, Nemecek E, Wahlstrom J, Kitko C, Lewis V, Schechter T, et al.
Blood
. 2019 May;
134(3):304-316.
PMID: 31043425
Chronic graft-versus-host disease (cGVHD) and late acute graft-versus-host disease (L-aGVHD) are understudied complications of allogeneic hematopoietic stem cell transplantation in children. The National Institutes of Health Consensus Criteria (NIH-CC) were...
9.
Pai A, Swain A, Chen F, Hwang W, Vega G, Carlson O, et al.
Biol Blood Marrow Transplant
. 2019 Mar;
25(7):1374-1381.
PMID: 30878608
Family psychosocial risk screening is an important initial step in delivering evidence-based care in hematopoietic stem cell transplantation (HCT). Establishing an evidence-based screening approach that is acceptable, reliable, and valid...
10.
Saad A, Taneja A, Di Stasi A, Sarmad R, Kukkamalla R, Costa L, et al.
Bone Marrow Transplant
. 2018 May;
53(10):1345-1348.
PMID: 29728698
No abstract available.